MODIFICATION TO PRECISION XTRA ADVANCED DIABETES MANAGEMENT SYSTEM

System, Test, Blood Glucose, Over The Counter

ABBOTT LABORATORIES

The following data is part of a premarket notification filed by Abbott Laboratories with the FDA for Modification To Precision Xtra Advanced Diabetes Management System.

Pre-market Notification Details

Device IDK040814
510k NumberK040814
Device Name:MODIFICATION TO PRECISION XTRA ADVANCED DIABETES MANAGEMENT SYSTEM
ClassificationSystem, Test, Blood Glucose, Over The Counter
Applicant ABBOTT LABORATORIES 4-A CROSBY DR. Bedford,  MA  01730 -1402
ContactTracey H Wielinski
CorrespondentTracey H Wielinski
ABBOTT LABORATORIES 4-A CROSBY DR. Bedford,  MA  01730 -1402
Product CodeNBW  
Subsequent Product CodeJIN
Subsequent Product CodeLFR
CFR Regulation Number862.1345 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeSpecial
3rd Party ReviewedNo
Combination ProductNo
Date Received2004-03-30
Decision Date2004-04-15
Summary:summary

NIH GUDID Devices

Device IdentifiersubmissionNumberSupplement
30093815998373 K040814 000
30093815988145 K040814 000
30093815715024 K040814 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.